Michael E. Severino
2017
In 2017, Michael E. Severino earned a total compensation of $8.4M as Executive Vice President, Research & Development and Chief Scientific Officer at AbbVie, a 16% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $653,582 |
|---|---|
| Non-Equity Incentive Plan | $1,955,069 |
| Option Awards | $980,980 |
| Salary | $1,004,460 |
| Stock Awards | $3,681,906 |
| Other | $119,279 |
| Total | $8,395,276 |
Severino received $3.7M in stock awards, accounting for 44% of the total pay in 2017.
Severino also received $653.6K of change in pension value and nonqualified deferred compensation earnings, $2M in non-equity incentive plan, $981K in option awards, $1M in salary and $119.3K in other compensation.
Rankings
In 2017, Michael E. Severino's compensation ranked 882nd out of 14,666 executives tracked by ExecPay. In other words, Severino earned more than 94.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 882 out of 14,666 | 94th |
Division Manufacturing | 299 out of 5,770 | 95th |
Major group Chemicals And Allied Products | 76 out of 2,074 | 96th |
Industry group Drugs | 53 out of 1,730 | 97th |
Industry Pharmaceutical Preparations | 43 out of 1,329 | 97th |
Source: SEC filing on March 19, 2018.
Severino's colleagues
We found four more compensation records of executives who worked with Michael E. Severino at AbbVie in 2017.